The IBAL technology (Ion Biotechnology Aqueous Ligands) represents a new class of therapeutic innovation based on […]
The IBAL technology (Ion Biotechnology Aqueous Ligands) represents a new class of therapeutic innovation based on […]
The Preclinical Safety Studies on IBAL-based formulations such as ION-ZCM1 and Ion Gel ZCM-25® form the […]
Preliminary Evaluation of ION-ZC1 as a Potential Anticancer Agent In Vitro Completed in 2018 by Brooklyn […]
Antimicrobial Efficacy Studies are essential in validating the performance of innovative bioactive compounds such as ION-ZCM1, […]
Clinical Phase 1 Human Safety Study The Human Clinical Studies conducted on Ion Gel ZCM-25® represent […]
